X
CERE

Xponance’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Xponance’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-8,638
Closed -$353K – 1405
2024
Q2 		$353K Buy
+8,638
New +$353K ﹤0.01% 1007